Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits May 17, 2016
Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study May 17, 2016
Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression May 12, 2016
Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine May 12, 2016
